Clinical Trial Update: A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, pharmacokinetics, and pharmacodynamics of AG-348 (mitapivat) in adults with non-transfusion-dependent th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thalassemia

Drugs mentioned

• Mitapivat (mitapivat)

Snippet

Sponsor: Agios Pharmaceuticals, Inc. | Conditions: Thalassemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-11-15